KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Liabilities and Shareholders Equity (2016 - 2026)

Silicon Laboratories has reported Liabilities and Shareholders Equity over the past 17 years, most recently at $1.3 billion for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity rose 3.81% year-over-year to $1.3 billion; the TTM value through Jan 2026 reached $5.0 billion, down 1.84%, while the annual FY2026 figure was $1.3 billion, 3.81% up from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 was $1.3 billion at Silicon Laboratories, up from $1.3 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $3.0 billion in Q1 2022 and troughed at $1.2 billion in Q3 2025.
  • A 5-year average of $1.7 billion and a median of $1.4 billion in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 52.02% in 2022 and later tumbled 37.81% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $2.2 billion in 2022, then crashed by 33.48% to $1.4 billion in 2023, then decreased by 15.27% to $1.2 billion in 2024, then increased by 2.49% to $1.3 billion in 2025, then rose by 1.3% to $1.3 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for SLAB at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.2 billion in Q3 2025.